Experienced in HNRNPH2-Related Disorder

Dr. Orrin Devinsky

Neurology | General Surgery
NYU Langone Health
New York University
223 E 34th St, 
New York, NY 
Offers Telehealth

Experienced in HNRNPH2-Related Disorder
NYU Langone Health
New York University
223 E 34th St, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Orrin Devinsky is a Neurologist and a General Surgeon in New York, New York. Dr. Devinsky is rated as an Experienced provider by MediFind in the treatment of HNRNPH2-Related Disorder. His top areas of expertise are Myoclonic Epilepsy, Dravet Syndrome, Seizures, Epilepsy, and Deep Brain Stimulation.

His clinical research consists of co-authoring 536 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of HNRNPH2-Related Disorder.

Specialties
Neurology
General Surgery
Licenses
Psychiatry & Neurology in NJ
Hospital Affiliations
Nyu Langone Hospitals
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MetroPlus Health
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Nippon Life
  • INSURANCE PLAN
Northwell Health
  • INSURANCE PLAN
Oscar
  • EPO
  • HMO
  • PPO
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

NEW YORK UNIVERSITY
223 E 34th St, New York, NY 10016
Call: 646-558-0800
Other Locations
NEW YORK UNIVERSITY
111 Broadway, New York, NY 10006
Call: 212-263-9700

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)
A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)
Enrollment Status: Terminated
Publish Date: October 08, 2025
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
Human Epilepsy Project 3: Newly Diagnosed Idiopathic Generalized Epilepsy
Human Epilepsy Project 3: Newly Diagnosed Idiopathic Generalized Epilepsy
Enrollment Status: Active_not_recruiting
Publish Date: July 04, 2025
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Young Adult Subjects With Dravet Syndrome (DS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Young Adult Subjects With Dravet Syndrome (DS)
Enrollment Status: Completed
Publish Date: January 01, 2025
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
Enrollment Status: Completed
Publish Date: August 21, 2024
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
A Phase 2 Study of Cannabidiol as a New Treatment for Autism Spectrum Disorder in Children and Adolescents
A Phase 2 Study of Cannabidiol as a New Treatment for Autism Spectrum Disorder in Children and Adolescents
Enrollment Status: Completed
Publish Date: May 31, 2024
Intervention Type: Drug
Study Drug: Cannabidiol
Study Phase: Phase 2
Fenfluramine in CKDL5 Deficiency Disorder (CDD)
Fenfluramine in CKDL5 Deficiency Disorder (CDD)
Enrollment Status: Completed
Publish Date: October 04, 2023
Intervention Type: Drug
Study Drug: Fenfluramine hydrochloride
Study Phase: Phase 2
A Multicenter, Open-Label Proof-of-Concept Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies Followed by 52 Week Open-Label Treatment
A Multicenter, Open-Label Proof-of-Concept Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies Followed by 52 Week Open-Label Treatment
Enrollment Status: Completed
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Ganaxolone
Study Phase: Phase 2
A Phase 2 Randomized, Double-Masked Placebo-Controlled Crossover Safety and Tolerability Study of Ataluren for Drug Resistant Epilepsy in Patients With Nonsense Mutation CDKL5 or Dravet Syndrome
A Phase 2 Randomized, Double-Masked Placebo-Controlled Crossover Safety and Tolerability Study of Ataluren for Drug Resistant Epilepsy in Patients With Nonsense Mutation CDKL5 or Dravet Syndrome
Enrollment Status: Completed
Publish Date: February 16, 2023
Intervention Type: Drug
Study Drug: Ataluren
Study Phase: Phase 2
View 7 Less Clinical Trials

536 Total Publications

A probabilistic functional atlas based on extraoperative electrocortical stimulation mapping.
A probabilistic functional atlas based on extraoperative electrocortical stimulation mapping.
Journal: bioRxiv : the preprint server for biology
Published: September 26, 2025
View All 536 Publications
Similar Doctors
Elite in HNRNPH2-Related Disorder
Dr. Jennifer M. Bain
Pediatric Neurology | Neurology
Elite in HNRNPH2-Related Disorder
Dr. Jennifer M. Bain
Pediatric Neurology | Neurology

Trustees Of Columbia University In The City Of New York

51 W 51st St, Fl 3 Suite 360, 
New York, NY 
 (1.1 miles away)
212-326-8426
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jennifer Bain is a Pediatric Neurologist and a Neurologist in New York, New York. Dr. Bain is rated as a Distinguished provider by MediFind in the treatment of HNRNPH2-Related Disorder. Her top areas of expertise are HNRNPH2-Related Disorder, Autism Spectrum Disorder, Early Infantile Epileptic Encephalopathy, and Cerebral Palsy.

Experienced in HNRNPH2-Related Disorder
Dr. John T. Hughes
Neurology
Experienced in HNRNPH2-Related Disorder
Dr. John T. Hughes
Neurology

John T. Hughes, M.D.

275 North Street, 
Newburgh, NY 
 (55.0 miles away)
845-391-8850
Experience:
43+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John Hughes is a Neurologist in Newburgh, New York. Dr. Hughes has been practicing medicine for over 43 years and is rated as a Distinguished provider by MediFind in the treatment of HNRNPH2-Related Disorder. His top areas of expertise are Peripheral Neuropathy, Autosomal Dominant Partial Epilepsy with Auditory Features, Benign Paroxysmal Positional Vertigo, and Essential Tremor. Dr. Hughes is currently accepting new patients.

Experienced in HNRNPH2-Related Disorder
Dr. Emma C. Laureta
Pediatric Neurology | Pediatrics | Neurology
Experienced in HNRNPH2-Related Disorder
Dr. Emma C. Laureta
Pediatric Neurology | Pediatrics | Neurology
3415 Bainbridge Avenue At Gunhill Road, 
Bronx, NY 
 (10.6 miles away)
718-920-4378
Languages Spoken:
English
See accepted insurances

Emma Laureta is a Pediatric Neurologist and a Pediatrics provider in Bronx, New York. Dr. Laureta is rated as an Advanced provider by MediFind in the treatment of HNRNPH2-Related Disorder. Her top areas of expertise are Generalized Tonic-Clonic Seizure, Seizures, Epilepsy Juvenile Absence, and Epilepsy.

VIEW MORE HNRNPH2-RELATED DISORDER DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Devinsky's expertise for a condition
ConditionClose
  • Elite
  • Absence Seizure
    Dr. Devinsky is
    Elite
    . Learn about Absence Seizure.
    See more Absence Seizure experts
  • Cortical Dysplasia
    Dr. Devinsky is
    Elite
    . Learn about Cortical Dysplasia.
    See more Cortical Dysplasia experts
  • Dravet Syndrome
    Dr. Devinsky is
    Elite
    . Learn about Dravet Syndrome.
    See more Dravet Syndrome experts
  • Epilepsy
    Dr. Devinsky is
    Elite
    . Learn about Epilepsy.
    See more Epilepsy experts
  • Epilepsy with Myoclonic-Atonic Seizures
    Dr. Devinsky is
    Elite
    . Learn about Epilepsy with Myoclonic-Atonic Seizures.
    See more Epilepsy with Myoclonic-Atonic Seizures experts
  • Generalized Tonic-Clonic Seizure
    Dr. Devinsky is
    Elite
    . Learn about Generalized Tonic-Clonic Seizure.
    See more Generalized Tonic-Clonic Seizure experts
View All 13 Elite Conditions
  • Distinguished
  • Epilepsy in Children
    Dr. Devinsky is
    Distinguished
    . Learn about Epilepsy in Children.
    See more Epilepsy in Children experts
  • Genetic Epilepsy with Febrile Seizures Plus (GEFS+)
    Dr. Devinsky is
    Distinguished
    . Learn about Genetic Epilepsy with Febrile Seizures Plus (GEFS+).
    See more Genetic Epilepsy with Febrile Seizures Plus (GEFS+) experts
  • KBG Syndrome
    Dr. Devinsky is
    Distinguished
    . Learn about KBG Syndrome.
    See more KBG Syndrome experts
  • Lafora Disease
    Dr. Devinsky is
    Distinguished
    . Learn about Lafora Disease.
    See more Lafora Disease experts
  • Partial Familial Epilepsy
    Dr. Devinsky is
    Distinguished
    . Learn about Partial Familial Epilepsy.
    See more Partial Familial Epilepsy experts
  • Partial Seizure
    Dr. Devinsky is
    Distinguished
    . Learn about Partial Seizure.
    See more Partial Seizure experts
View All 10 Distinguished Conditions
  • Advanced
  • Autism Spectrum Disorder
    Dr. Devinsky is
    Advanced
    . Learn about Autism Spectrum Disorder.
    See more Autism Spectrum Disorder experts
  • Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)
    Dr. Devinsky is
    Advanced
    . Learn about Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE).
    See more Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) experts
  • Autosomal Dominant Partial Epilepsy with Auditory Features
    Dr. Devinsky is
    Advanced
    . Learn about Autosomal Dominant Partial Epilepsy with Auditory Features.
    See more Autosomal Dominant Partial Epilepsy with Auditory Features experts
  • Central Sleep Apnea
    Dr. Devinsky is
    Advanced
    . Learn about Central Sleep Apnea.
    See more Central Sleep Apnea experts
  • Encephalitis
    Dr. Devinsky is
    Advanced
    . Learn about Encephalitis.
    See more Encephalitis experts
  • Infant Epilepsy with Migrant Focal Crisis
    Dr. Devinsky is
    Advanced
    . Learn about Infant Epilepsy with Migrant Focal Crisis.
    See more Infant Epilepsy with Migrant Focal Crisis experts
View All 9 Advanced Conditions
  • Experienced
  • Alzheimer's Disease
    Dr. Devinsky is
    Experienced
    . Learn about Alzheimer's Disease.
    See more Alzheimer's Disease experts
  • Arteriovenous Malformation
    Dr. Devinsky is
    Experienced
    . Learn about Arteriovenous Malformation.
    See more Arteriovenous Malformation experts
  • Astrocytoma
    Dr. Devinsky is
    Experienced
    . Learn about Astrocytoma.
    See more Astrocytoma experts
  • Benign Rolandic Epilepsy
    Dr. Devinsky is
    Experienced
    . Learn about Benign Rolandic Epilepsy.
    See more Benign Rolandic Epilepsy experts
  • Brain Tumor
    Dr. Devinsky is
    Experienced
    . Learn about Brain Tumor.
    See more Brain Tumor experts
  • Continuous Spike-Wave During Slow Sleep Syndrome
    Dr. Devinsky is
    Experienced
    . Learn about Continuous Spike-Wave During Slow Sleep Syndrome.
    See more Continuous Spike-Wave During Slow Sleep Syndrome experts
View All 28 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved